Davis Polk & Wardwell advised Williams on the transaction, and Milbank advised Hartree. Williams (NYSE: WMB) announced that it has closed its acquisition of a portfolio...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Lightyear Capital on the deal. Ygrene Energy Fund Inc. closed its Series C funding round, with participation from Lightyear Capital and Virgo Investment Group. Founded...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Charles River Laboratories International on the deal. Charles River Laboratories International, Inc. announced its $295 million acquisition of Explora BioLabs Holdings, Inc. Charles...
You must be a Standard 1 Year member to access this content.
Davis Polk advised BlueVoyant in the transaction. Paul, Weiss advised Liberty Strategic Capital. BlueVoyant closed its $250 million Series D funding round led by Liberty Strategic Capital,...
You must be a Standard 1 Year member to access this content.
Davis Polk advised BDT Capital Partners on the deal. BDT Capital Partners, LLC executed its acquisition through its affiliated funds of MJH Life Sciences. The Hennessy...
You must be a Standard 1 Year member to access this content.
